Compare StocksABBV vs DHR

AbbVie Inc. (ABBV) vs Danaher Corporation (DHR): Which Is the Better Buy in 2026?

As of 2026-06-21, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. DHR is overvalued at $177, with an intrinsic value of $136 and a margin of safety of -30%. Of the two, DHR has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
DHR
Danaher Corporation
$177.17

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
DHR
  • Altman Z-Score of 4.49 indicates very low bankruptcy risk — the company is firmly in the safe zone.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 106.1x is 70% above the historical average of 62.3x — the stock trades at a premium to its own history.
DHR
  • Buybacks have been poorly timed — 2 out of 2 years involved repurchases at relatively expensive valuations.
  • 9 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.
  • Free cash flow has declined at a 10.8% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
ABBV
DHR
Valuation
$20.81B
Free Cash Flow
$4.57B
5.44%
FCF Yield
3.64%
106.12
Trailing P/E
34.34
13.32
Forward P/E
19.15
Quality & Moat
21.89%
ROIC
6.18%
N/A
ROE
7.08%
72.03%
Gross Margin
58.99%
0.60
PEG Ratio
1.13
Balance Sheet Safety
N/A
Net Debt / Equity
0.26
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
1.76
3.20%
Dividend Yield
0.90%
ABBV: 7Ties: 1DHR: 2
ABBVDHR

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

DHR

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
DHR
$-1.02
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$9.38B
Δ Market Cap
$-9.55B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
DHR
30.1% Overvalued
Price is 30.1% above estimated fair value
Current Price: $177.17
Fair Value: $136.18
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

DHR

What growth rate is the market pricing in at $177?

+12.5%
Market-Implied Owner Earnings Growth
Standard FCF implies +13.4%

The market implies +12.5% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +13.4%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
DHR
46/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
DHR
-2.58
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.8%Retail & Other 23.0%
No. of Institutional Holders5,110
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
DHR
Insiders 10.7%Institutions 84.7%Retail & Other 4.5%
No. of Institutional Holders2,931
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
DHR
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
DHR
1
Sells (3M)
9
Sells (12M)
Total value (12M): $236.38M
SPOON ALAN G
Director
$237,207
@ $174.67 · 2026-05-01
MILOSEVICH GREGORY M
Officer
$274,575
@ $208.01 · 2026-02-19
LIST TERI
Director
$746,997
@ $226.50 · 2025-11-18
ELLIS BRIAN W
General Counsel
$4.77M
@ $219.23 · 2025-11-12
RALES MITCHELL P
Officer and Director
$95.57M
@ $218.69 · 2025-11-12
MCGREW MATTHEW
Chief Financial Officer
$3.47M
@ $214.62 · 2025-11-11
COUCHARA GEORGEANN F.
Officer
$1.09M
@ $210.42 · 2025-11-10
RALES MITCHELL P
Officer and Director
$129.64M
@ $216.06 · 2025-10-31
LIST-STOLL TERI L.
Director
$586,319
@ $211.06 · 2025-08-22
RALES STEVEN M
Chairman of the Board
$245.92M
@ $196.74 · 2025-05-12
RILEY CHRISTOPHER PAUL
Officer
$3.13M
@ $198.00 · 2025-04-30
SPOON ALAN G
Director
$113,553
@ $206.46 · 2025-02-07
ELLIS BRIAN W
General Counsel
$1.28M
@ $224.13 · 2025-01-30
RASKAS DANIEL A
Officer
$8.22M
@ $236.93 · 2024-11-26
COUCHARA GEORGEANN F.
Officer
$255,483
@ $268.36 · 2024-08-26
MCGREW MATTHEW
Chief Financial Officer
$4.53M
@ $279.84 · 2024-08-01
FILLER LINDA
Director
$1.10M
@ $279.50 · 2024-08-01
BLAIR RAINER M
Chief Executive Officer
$2.52M
@ $280.00 · 2024-07-31
RASKAS DANIEL A
Officer
$3.92M
@ $270.51 · 2024-07-25
ELLIS BRIAN W
General Counsel
$2.64M
@ $275.16 · 2024-07-25
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
DHR
FearGreed
😐Neutral(41/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
DHR
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (41)
View ABBV Full AnalysisView DHR Full Analysis

Frequently Asked Questions: ABBV vs DHR

Is AbbVie Inc. or Danaher Corporation more undervalued in 2026?

Based on our discounted cash flow model, DHR trades at a -30.1% margin of safety (intrinsic value $136 vs. price $177), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which stock has a wider economic moat, AbbVie Inc. or Danaher Corporation?

ABBV scores 82/100 (Wide moat), while DHR scores 46/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. DHR scores 4.5 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Danaher Corporation?

AbbVie Inc. (ABBV) generates a 5.4% free cash flow yield, compared to Danaher Corporation's 3.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Danaher Corporation?

ABBV earns 21.9% ROIC versus DHR's 6.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Danaher Corporation's?

DHR's dividend earns a safety score of 88/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). DHR has raised its dividend for 1 consecutive years.